EP0853486A3 - Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes - Google Patents

Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes

Info

Publication number
EP0853486A3
EP0853486A3 EP96932773.3A EP96932773A EP0853486A3 EP 0853486 A3 EP0853486 A3 EP 0853486A3 EP 96932773 A EP96932773 A EP 96932773A EP 0853486 A3 EP0853486 A3 EP 0853486A3
Authority
EP
European Patent Office
Prior art keywords
viral
aids
cancer
treatment
therapeutic applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP96932773.3A
Other languages
German (de)
English (en)
Other versions
EP0853486A2 (fr
EP0853486A4 (fr
Inventor
Samir Chachoua
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IB1996/001115 external-priority patent/WO1997011667A2/fr
Publication of EP0853486A3 publication Critical patent/EP0853486A3/fr
Publication of EP0853486A2 publication Critical patent/EP0853486A2/fr
Publication of EP0853486A4 publication Critical patent/EP0853486A4/fr
Withdrawn legal-status Critical Current

Links

EP96932773A 1995-09-25 1996-09-25 Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes Withdrawn EP0853486A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US428195P 1995-09-25 1995-09-25
US4281P 1995-09-25
PCT/IB1996/001115 WO1997011667A2 (fr) 1995-09-25 1996-09-25 Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes

Publications (3)

Publication Number Publication Date
EP0853486A3 true EP0853486A3 (fr) 1997-06-12
EP0853486A2 EP0853486A2 (fr) 1998-07-22
EP0853486A4 EP0853486A4 (fr) 2001-09-26

Family

ID=21710013

Family Applications (2)

Application Number Title Priority Date Filing Date
EP96931214A Withdrawn EP0858327A2 (fr) 1995-09-25 1996-09-25 Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies
EP96932773A Withdrawn EP0853486A4 (fr) 1995-09-25 1996-09-25 Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP96931214A Withdrawn EP0858327A2 (fr) 1995-09-25 1996-09-25 Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies

Country Status (5)

Country Link
EP (2) EP0858327A2 (fr)
JP (1) JPH11514990A (fr)
AU (2) AU6999096A (fr)
CA (2) CA2233445A1 (fr)
WO (2) WO1997011667A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994409A (en) 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6384259B1 (en) 1998-11-16 2002-05-07 Medimmune Oncology, Inc. Stable amorphous amifostine compositions and dosage form
US7939109B1 (en) * 1999-10-04 2011-05-10 John Carter Method of treating neoplastic disease in a human or animal patient
US7927612B2 (en) 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
US6811788B2 (en) 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
FR2825923B1 (fr) * 2001-06-15 2006-04-07 Oreal Inhibiteur de no-synthase et utilisations
KR20030077743A (ko) * 2002-03-26 2003-10-04 변현규 In½
US7629333B2 (en) 2002-03-29 2009-12-08 Medimmune, Llc Stable amorphous amifostine compositions and methods for the preparation and use of same
AU2002353346A1 (en) * 2002-09-10 2004-04-30 Samir Chachoua Induced remission therapy
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
CN101138634A (zh) 2006-09-07 2008-03-12 于保法 用于治疗肿瘤的组合物
EP2278984A4 (fr) 2007-11-30 2013-02-27 Ramaekers Family Trust Compositions et procédés d'amélioration de la fertilité
WO2010093606A1 (fr) * 2009-02-11 2010-08-19 Martin Heath Bluth Echange réciproque sérum/plasma pour le traitement du cancer
US11110303B2 (en) 2014-11-26 2021-09-07 Baofa Yu Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228127A (en) * 1978-10-06 1980-10-14 International Radioimmune Systems, Inc. Kit for detecting human chorionic gonadotropin
US4952607A (en) * 1982-05-27 1990-08-28 International Copper Research Association, Inc. Copper complex for treating cancer
US5057314A (en) * 1988-09-30 1991-10-15 Whitfill Craig E Low molecular weight antiviral factors
US5310653A (en) * 1989-10-24 1994-05-10 Board Of Regents, The University Of Texas System Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis
US5488042A (en) * 1992-03-13 1996-01-30 Arch Development Corporation Method for protection against genotoxic mutagenesis
DE4236069A1 (de) * 1992-10-26 1994-04-28 Werner Dr Bergmann Arzneimittel, insbesondere für orale Einnahme
WO1994028934A1 (fr) * 1993-06-07 1994-12-22 Center For Special Immunology Traitement adoptif de reconstitution immunitaire pour des patients atteints d'immunodeficiences acquises

Similar Documents

Publication Publication Date Title
EP0853486A3 (fr) Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes
EP0853486A4 (fr) Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes
AU3066992A (en) Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
AU2993297A (en) Treatment of sickle cell disease, treatment of immune system diseases and other diseases normally associated with sickle cell anemia
EP0831873A4 (fr) Therapie combinatoire pour le traitement d'infections virales vih et autres
PL319021A1 (en) Body weight modulators, appropriate nucleic acid and proteins and their diagnostic and therapeutic application
EP2270046A3 (fr) Procédés et compositions pour le traitement des maladies associées à hémolyse
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU9312198A (en) Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU7739396A (en) Flow cytometric pharmacosensitivity assay and method of cancer treatment
AU6282896A (en) Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
AU3092995A (en) Breast specific genes and proteins
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
AU2796799A (en) Amplification of gene transfer and gene therapy by controlled replication
CA2271478A1 (fr) Expression specifique tissulaire de la proteine du retinoblastome
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU8168898A (en) Interferon stimulating protein and uses thereof
AU5369396A (en) Rest protein and dna
AU3530395A (en) Treatment of viral infections
AU6777596A (en) Treatment of human prostate disease with beta-lapachone derivatives
GB9509461D0 (en) DNA molecules and constructs and their use in the treatment of mastitis